Information about Juvise Pharmaceutical
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0863.588.327

VAT liability
No
Established
19-06-2003
Last balance sheet year
2024
Company size
Micro 0 FTE
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Juvise Pharmaceutical

2024 2023 2022 2021
Profit/Loss -2,288 -50 % -1,521 -7 % -1,420 12 % -1,607
Equity -226,375 -1 % -224,087 -1 % -222,566 -1 % -221,146
Gross margin -2,246 -52 % -1,478 -8 % -1,366 11 % -1,531

Publications from Juvise Pharmaceutical

Date Publication
28-06-2016 Registered Office (FR)
28-12-2009 Registered Office (FR)
23-02-2006 Registered Office Relocation (FR)
27-06-2003 Constitution (FR)

Frequently asked questions

What is the enterprise number of Juvise Pharmaceutical?
The enterprise number of Juvise Pharmaceutical is BE 0863.588.327.
Wat is the PEPPOL ID of Juvise Pharmaceutical?
There is no information available about the PEPPOL ID of Juvise Pharmaceutical or the company is not yet registered on the PEPPOL network.
When was Juvise Pharmaceutical founded?
Juvise Pharmaceutical was founded on 19-06-2003.
What is the address of Juvise Pharmaceutical?
The current registered office of Juvise Pharmaceutical is located at Buro and Design Center Heizel E 1/86, 1020 Bruxelles.
When was the last time Juvise Pharmaceutical filed their annual financial statements?
The most recent financial statements of Juvise Pharmaceutical were filed on 11-06-2025.
How many employees does Juvise Pharmaceutical have?
There are currently no employees working at Juvise Pharmaceutical or no workforce information is available.
What is the annual turnover of Juvise Pharmaceutical?
At the time of its most recent financial statements, Juvise Pharmaceutical did not publish any turnover figures. Juvise Pharmaceutical reported a gross margin of -€2,246.07.